Jaideep Gogtay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jaideep gogtay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jaideep Gogtay Today - Breaking & Trending Today

Timely diagnosis and treatment can help slow down the progression of COPD says India's pulmonologists

New Delhi [India], December 27 (ANI/Mediawire): Chronic Obstructive Pulmonary Disease, also known as COPD, is a progressive lung disease that compromises the lung's ability to function, thus making it harder for a person to breathe and hampering their health and productivity. The condition leads to swelling in individuals' airways and damage to their lungs due to exposure to toxins outside of the body, which restricts airflow and makes it more difficult for them to breathe. Statistics show that the disease impacts 1 in every 6 Indians, making it the second leading cause of disease burden in India right after heart disease. Globally, it is the third leading cause of death which has contributed to 3.23 million deaths as of 2019. Multiple factors can result in people developing COPD over time. According to Dr Satyanarayana Mysore, Consultant Pulmonologist, Bangalore said, "COPD is estimated to affect about 7.4 per cent of the Indian population. Factors like active and passive ....

Andhra Pradesh , New Delhi , Sandeep Nayar , Pratibha Singhal , Jaideep Gogtay , Cipla Ltd , Chronic Obstructive Pulmonary Disease , Consultant Pulmonologist , Consultant Chest Physician , Critical Care , Sleep Disorder Specialist , Global Chief Medical Officer , Cipla Ltd For , New Delhi India , Ecember 27 Ani Mediawire Chronic Obstructive Pulmonary Disease , Lso Known As Copd , Sa Progressive Lung Disease That Compromises The 39s Ability To Function , Hus Making It Harder Fora Person To Breathe And Hampering Their Health Productivity The Condition Leads Swelling In Individuals 39 Airways Damage Lungs Due Exposure Toxins Outside Of Body , Hich Restricts Airflow And Makes It More Difficult For Them To Breathe Statistics Show That The Disease Impacts 1 In Every 6 Indians , Aking It The Second Leading Cause Of Disease Burden In India Right After Heart Globally , T Is The Third Leading Cause Of Death Which Has Contributed To 3 23 Million Deaths As 2019 Multiple Factors Can Result In People Developing Copd Over Time According Dr Satyanarayana Mysore , Consultant Pulmonologist , Angalore Said , Uot Copd Is Estimated To Affect About 7 4 Per Cent Of The Indian Population Factors Like Active And Passive Smoking , Xposure To Environmental And Occupational Dust , Utdoor And Indoor Air Pollution ,

Lack of access to antibiotics is a key driver of antimicrobial resistance

Sustainable access to antibiotics in low- and middle-income countries is crucial ....

Jennifer Cohn , Jaideep Gogtay , Cipla Ltd , Global Antibiotic Research , Access To Medicines Foundation , World Health Organization , Development Partnership , World Antimicrobial Awareness Week , Medicines Foundation , Daily Newsletter ,

Covid-19: New nasal spray effective against all variants

Finnish researchers have developed a novel nasal spray that is effective against all variants of Covid and can prevent infection upto 8 hours. ....

Eteläuomen Läi , United Kingdom , City Of , Anna Makela , Jaideep Gogtay , Cipla Ltd , University Of Helsinki , Cocktail Therapy , Global Chief Medical Officer , Professor Kalle Saksela , Nasal Spray , Covid 19 ,

Behind the antibody cocktail rush in India's Covid-19 wave, profits for hospitals and pharma firms

On December 16, Regeneron said its cocktail drug had diminished potency against Omicron. But 13 days later, Cipla held a webinar to promote its use in India. ....

United States , United Kingdom , Anant Waibase , Sanjay Nagral , Eli Lilly , Jaideep Gogtay , Mahadev Waibase , Sudhakar Shinde , Regeneron Regen , Altaf Khan , India Central Drugs Standards Control Organisation , National Institute Of Health , Indian Council Of Medical Research , National Health Service , World Health Organisation On , Navi Mumbai , Kopar Khairane , Central Drugs Standards Control Organisation , World Health Organisation , National Institute , Indian Council , Medical Research , Umbai Third Wave Omicron Antibody Therapy Treatment , Micron Regen Cov Effective , Onoclonal Antibody Treatment Omicron Effectiveness , Onoclonal Antibody Drug Cocktail Cost ,

Cipla raises awareness on inhaler-adoption for asthma

India accounts for over 42% of all global asthma deaths ....

Jaideep Gogtay , Global Initiative For Asthma , Global Burden , Disease Report , Global Initiative , Global Chief Medical Officer ,